FIELD: medicine; gynecology.
SUBSTANCE: invention can be used for the complex treatment of menstrual disorders such as oligomenorrhea and amenorrhea in women of reproductive age with metabolic syndrome. Myo-inositol is administered orally at a dose of 2,000 mg 2 times a day, D-chiro-inositol at a dose of 400 mg 2 times a day from the 1st day of the menstrual cycle, if any, or on any day for amenorrhea, and additionally apply coenzyme Q10 at a dose of 100 mg 2 times a day for at least 6 months. This method provides a positive result with minimal or completely absent side effects, which allows to perform highly effective therapy in the periconception period and during pregnancy, restoring ovarian function and eliminating insulin resistance.
EFFECT: invention makes it possible to increase the effectiveness of treatment of menstrual disorders such as oligomenorrhea and amenorrhea in women of reproductive age with metabolic syndrome.
1 cl, 3 tbl, 3 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR TREATMENT OF POLYCYSTIC OVARY SYNDROME ASSOCIATED WITH METABOLIC SYNDROME | 2020 |
|
RU2749783C1 |
DIAGNOSTIC TECHNIQUE FOR HYPERANDROGENISM SYNDROME IN WOMEN OF REPRODUCTIVE AGE | 2010 |
|
RU2461354C2 |
PHARMACEUTICAL COMPOSITION FOR PREVENTING AND TREATING POLYCYSTIC OVARY SYNDROME | 2020 |
|
RU2757220C1 |
METHOD OF CHOOSING THERAPEUTIC APPROACH IN MENSTRUAL DISORDERS IN ADOLESCENT GIRLS WITH OVERWEIGHT | 2010 |
|
RU2422824C1 |
METHOD FOR TREATING CHRONIC ANOVULATION AND PREVENTING SYNDROME OF OVARIAN HYPERSTIMULATION | 1999 |
|
RU2201225C2 |
METHOD FOR TREATMENT OF POLYCYSTIC OVARY SYNDROME | 2017 |
|
RU2665969C1 |
METHOD FOR INTEGRATED TREATMENT OF OBESITY ACCOMPANYING POLYCYSTIC OVARY SYNDROME | 2014 |
|
RU2564439C1 |
METHOD FOR PREDICTION OF CLINICAL EFFECTIVENESS OF METFORMIN AND/OR WEIGHT-LOSS THERAPY IN PATIENTS WITH POLYCYSTIC OVARIAN SYNDROME | 2010 |
|
RU2427842C1 |
METHOD FOR PREDICTION OF DEVELOPMENT OF OVARIAN DYSFUNCTION AND EVALUATION OF CLINICAL EFFECTIVENESS IN ADOLESCENT GIRLS SUFFERING FROM OBESITY | 2019 |
|
RU2743728C1 |
METHOD FOR SELECTING THERAPEUTIC APPROACH TO FEMALE PATIENTS WITH OLIGOMENORRHEA AND OBESITY | 2014 |
|
RU2555347C1 |
Authors
Dates
2024-02-12—Published
2022-11-23—Filed